Cel-Sci completes direct public offering

Cel-Sci Corp. (NYSE-A:CVM), Vienna, Va. Business: Cancer, Infectious Date completed: 1/26/12 Type: Direct public offering Raised: $5.8 million Shares: 16 million Price: $0.36 Shares after offering: 24...